We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
-3.55%
1 Year Est. Return
+57.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.63B
AUM Growth
-$332M
Cap. Flow
-$165M
Cap. Flow %
-6.27%
Top 10 Hldgs %
27.16%
Holding
459
New
61
Increased
86
Reduced
158
Closed
50

Sector Composition

Rank Sector Weight
1 Healthcare 17.76%
2 Consumer Discretionary 17.69%
3 Technology 17.25%
4 Industrials 12.49%
5 Consumer Staples 10.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALJ
176
DELISTED
Alon USA Energy Inc
ALJ
$803K 0.03%
44,460
-51
-0.1% -$967
DTSI
177
DELISTED
DTS, Inc.
DTSI
$790K 0.03%
29,590
+630
+2% +$17.6K
AGEN
178
Agenus
AGEN
$291M
$789K 0.03%
8,741
-12
-0.1% -$1.78K
CTB
179
DELISTED
Cooper Tire & Rubber Co.
CTB
$774K 0.03%
19,581
+18,884
+2,709% +$687K
SCAI
180
DELISTED
Surgical Care Affiliates, Inc.
SCAI
$774K 0.03%
23,680
-10
-0% -$375
RPXC
181
DELISTED
RPX Corporation
RPXC
$755K 0.03%
55,000
-10
-0% -$148
CLVS
182
DELISTED
Clovis Oncology, Inc.
CLVS
$738K 0.03%
8,030
-51
-0.6% -$4.41K
NAVG
183
DELISTED
Navigators Group Inc
NAVG
$717K 0.03%
18,386
GNCA
184
DELISTED
Genocea Biosciences, Inc.
GNCA
$712K 0.03%
12,984
-20
-0.2% -$1.98K
HALO icon
185
Halozyme
HALO
$12.2B
$673K 0.03%
+50,080
New +$1.01M
INFI
186
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$632K 0.02%
74,770
-806
-1% -$7.43K
ADXS
187
DELISTED
Advaxis Inc
ADXS
$624K 0.02%
+4,068
New +$984K
AXAS
188
DELISTED
Abraxas Petroleum Corp
AXAS
$614K 0.02%
23,991
-52
-0.2% -$1.94K
RSTI
189
DELISTED
Rofin-Sinar Technologies Inc
RSTI
$601K 0.02%
+23,180
New +$588K
CTIC
190
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$597K 0.02%
40,907
-8
-0% -$138
MACK
191
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$554K 0.02%
8,278
-3
-0% -$245
MTEM
192
DELISTED
Molecular Templates, Inc.
MTEM
$545K 0.02%
+811
New +$577K
CPLA
193
DELISTED
Capella Education Company
CPLA
$518K 0.02%
10,462
MDGL icon
194
Madrigal Pharmaceuticals
MDGL
$11.9B
$489K 0.02%
8,035
-2
-0% -$144
ANAC
195
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$484K 0.02%
+4,110
New +$537K
PFNX
196
DELISTED
Pfenex Inc.
PFNX
$479K 0.02%
+31,910
New +$648K
FRTX
197
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$438K 0.02%
302
+104
+53% +$201K
PES
198
DELISTED
Pioneer Energy Services Corp.
PES
$418K 0.02%
199,220
-54,640
-22% -$186K
NVO
199
Novo Nordisk
NVO
$211B
$263K 0.01%
9,710
RYAAY icon
200
Ryanair
RYAAY
$30.9B
$262K 0.01%
8,166

Similar funds

Smith Group Asset Management's Q3 2015 Portfolio in Review

As of Q3 2015, Smith Group Asset Management held 459 positions worth $2.63B, down 11% from $2.97B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Smith Group Asset Management withdrew a net $165M in Q3 2015, closing 50 positions and reducing 158 holdings. Its most notable exit was DST Systems Inc., an estimated $64.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Smith Group Asset Management opened a new position in Citrix Systems Inc worth $31.4M.

  • Smith Group Asset Management's largest Q3 2015 buy was Citrix Systems Inc: 569,631 shares worth $31.4M.
  • Smith Group Asset Management added most to Foot Locker in Q3 2015, an estimated $31.9M increase.
  • Smith Group Asset Management's biggest Q3 2015 reduction was United Therapeutics, cutting an estimated $24.4M.
  • Smith Group Asset Management fully exited DST Systems Inc. in Q3 2015, selling an estimated $64.8M.
  • Smith Group Asset Management's ten largest holdings make up 27% of its $2.63B portfolio in Q3 2015.
  • Smith Group Asset Management opened 61 new positions and closed 50 in Q3 2015.
  • Smith Group Asset Management's portfolio value fell 11% quarter-over-quarter to $2.63B.

Based on Smith Group Asset Management's 13F filing for Q3 2015, filed 23 Oct 2015.